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EpigeneticsIllumina Inﬁnium Human Methylation (HM) BeadChips are widely used for measuring genome-scale DNA
methylation, particularly in relation to epigenome-wide association studies (EWAS) studies. The methylation
proﬁle of human samples can be assessed accurately and reproducibly using the HM27 BeadChip (27,578 CpG
sites) or its successor, the HM450 BeadChip (482,421 CpG sites). To date no mouse equivalent has been de-
veloped, greatly hindering the application of this methodology to the wide range of valuable murine models
of disease and development currently in existence. We found 1308 and 13,715 probes from HM27 and
HM450 BeadChip respectively, uniquely matched the bisulﬁte converted reference mouse genome (mm9).
We demonstrate reproducible measurements of DNA methylation at these probes in a range of mouse tissue
samples and in a murine cell line model of acute myeloid leukaemia. In the absence of a mouse counterpart,
the Inﬁnium Human Methylation BeadChip arrays have utility for methylation proﬁling in non-human
species.
© 2013 Elsevier Inc. All rights reserved.1. Introduction
The role of DNA methylation in various physiological processes and
related diseases is becoming increasingly apparent as the tools to study
this epigenetic mark at the genome-wide level become more devel-
oped. These can largely be categorized as those that directly measure
methylation at speciﬁc CpG sites within a biological sample and those
that utilize less speciﬁc afﬁnity-based approaches (such as antibody en-
richment) to generate a proﬁle of regionalmethylation formultiple CpG
sites [1]. The recent development of the sensitive and highly reproduc-
ible Inﬁnium Human Methylation BeadChip arrays [2] has greatly ex-
panded the potential of studies exploring genome-scale methylation
in development and disease. However, for model organisms such as
the mouse, equivalent tools to study DNA methylation at a genome-
scale are not currently available. More labour intensive and less sensi-
tive methodologies are still required.r Research, Olivia Newton John
nt of Pathology, The University
.
rights reserved.Here we investigated the feasibility of interrogating the mouse ge-
nome for DNA methylation using the Illumina Inﬁnium HM27 and
HM450 platforms. Such cross species array experiments have been
performed in the past for gene expression analysis of species where
a microarray has not been available [3,4]. Probes from the array of a
closely related species that perfectly match the test species genome
have been used to measure gene expression reliably [5].
The Illumina Inﬁnium chemistry relies on the hybridization of bisul-
ﬁte converted genomic DNA to 50-mer probes on the BeadChip. Base
extension chemistry is then employed to incorporate a ﬂuorescent nu-
cleotide onto each hybridized probe [6]. The Inﬁnium I chemistry used
by the HM27 BeadChip uses two probes (one for the methylated and
another for the unmethylated allele) per probe sequence and interro-
gated within the same colour channel. While the Inﬁnium II chemistry
uses one probe employing two colour chemistries to measure DNA
methylation [2], the HM450 BeadChip uses a combination of both
Inﬁnium Type I and Type II chemistries which needs to be accounted
for during downstream analysis [7,8].
Here, we determined the utility of the Inﬁnium HM27 and HM450
BeadChip for mouse genomic DNA. We ﬁrst performed in-silico map-
ping analysis using four popular short read aligners to the mouse ref-
erence genome in base space to determine the number of uniquely
39N.C. Wong et al. / Genomics 102 (2013) 38–46aligned probe sequences that could directly interrogate DNA methyl-
ation in mouse genomic DNA. We also performed mapping of
the probes to the bisulﬁte converted reference genome employing
four bisulﬁte sequence aligners. Mouse samples were then analysed
using HM27 and HM450 BeadChips in parallel to human samples to
empirically determine if the probes identiﬁed by in-silico analysis
are informative. Several probes demonstrating differential DNA
methylation in the mouse samples were replicated using
SEQUENOM EpiTYPER. We present a list of candidate probes that
could be used to investigate mouse DNA methylation using the
Human Methylation BeadChip in the absence of a mouse-speciﬁc
counterpart .2. Results
2.1. HM27 BeadChip in-silico analysis
We deﬁne unique mapping 100% identity across all 50 bp of the
query sequence to a single region of the reference genome. Therefore
the unique annotation in Table 1 is directly comparable between the
short read aligners used.
SHRiMP, BWA and Novoalign identiﬁed comparable numbers of
uniquely mapped HM27 probes to mm9 with 219, 219 and 236 probes
respectively. 219 probeswere identiﬁed using Blat (Table 1 and Fig. 1A).
These 219 probeswere called by all four aligners (Fig. 1A, Supplementa-
ry Table 1) and are likely to represent highly conserved sequences be-
tween the human and mouse reference genomes. To determine the
mappability of the probes, we performed probe sequence alignment
on the human reference genome, both with (hg19) and without refer-
ence haplotype sequences (hg19 nohap).
Of the 27,578 probes on the HM27 BeadChip, SHRiMP identiﬁed
26,905 uniquely mapped probes while BWA, Novoalign and Blat iden-
tiﬁed 26,951, 26,946 and 26,938 uniquely aligned probes respectively
(Table 1). 26,740 probes were found to uniquely align to hg19 by all
four aligners (Supplementary Table 2). No alignment was found for
two probes (cg03886110 and cg22467071) to the reference hg19 ge-
nome. The remaining probe sequences appear to align to multiple
non-unique locations in the hg19 reference genome. We found that
these probes mapped to the haplotype sequences of the hg19 refer-
ence genome. We then repeated our alignment analysis to a reference
genome where the haplotype sequences were excluded, the numberTable 1
Inﬁnium probe alignment summary.
Genome space Aligner Alignments HM27
mm9 h
Base space SHRiMP Mapped 1867 2
Mapped 50M 224 2
Unique 219 2
Multiple 5
BWA Mapped 1266 2
Unique 219 2
Novoalign Mapped 2515 2
Unique 236 2
Blat Mappeda 224 2
Unique 219 2
Multiple 5
Bisulﬁte space Novoalign BM Mapped 3739 2
Unique 3516 2
Not mapped 23,839
Bismark Mapped 1507 2
Unique 1451 2
Not mapped 26,071
Bsmap Mapped 1352 2
Brat Mapped 333 2
Unique requires alignment of 50M and no mismatches.
a Blat does not output in SAM format, we required 100% identity mapping alignment andof unique mapped probes increased when aligned to SHRiMP, BWA,
Novoalign and Blat (Table 1).
2.2. HM450 BeadChip in-silico analysis
We extended our analysis to the current generation HM450
BeadChip and performed probe sequence alignment to both the mouse
(mm9) and human (hg19) reference genomes. Of the 485,577 probes,
SHRiMP, BWA and Novoalign identiﬁed 1988, 1989 and 2076 probes
with unique alignment to mm9 respectively (Table 1). Blat identiﬁed
1988 probes uniquely aligning to mm9. Using all four aligners, 1989
probes aligned uniquely to mm9 (Fig. 1B, Supplementary Table 3). We
found a substantial number of probe sequences that appear to not
align uniquely to our reference genome hg19 with the number of per-
fectly aligned probes ranging from 467,862 to 485,277 across the four
base space aligners used (Table 1). As with the HM27 BeadChip, these
probes aligned to the haplotype sequences we included in our analysis.
Accounting for haplotype, the number of unique mapping probes in-
creased ranging from 482,785 to 485,293 (Table 1).
2.3. Accounting for bisulﬁte conversion of genomic DNA
Sodium bisulﬁte reduces the sequence complexity of genomic DNA
by converting all unmethylated cytosine bases to uracil that present as
a thymidine after PCR ampliﬁcation [9]. In addition, the DNA strands be-
come non-complementary. As the Inﬁnium BeadChip chemistry relies
on the hybridization of probes to bisulﬁte converted genomic DNA,
there is an increased likelihood that probes thought to uniquely align
in normal genome space can align to multiple locations across the ge-
nome after bisulﬁte conversion. The increased degeneracy induced by
bisulﬁte conversion could also increase the cross-reactivity of array
probes to other species such as mouse.
To investigate this, we took the probe sequences from theHM27 and
HM450 BeadChips, and bisulﬁte converted these sequences in-silico
and aligned them to the bisulﬁte converted mouse genome using four
short read alignment algorithms speciﬁcally designed for bisulﬁte mas-
sively parallel sequencing. We used Novoalign Bisulﬁte Mode (http://
www.novocraft.com), Brat [10], Bsmap [11] and Bismark [12].
Given the variation in output formats from these bisulﬁte short read
aligners, it was a challenge to extract probes that mapped uniquely
according to our deﬁnition above. Therefore, the mapped probes from
each aligner are presented in Table 1 and Figs. 1C and D.HM450
g19 hg19 nohap mm9 hg19 hg19 nohap
7,545 27,545 21,893 484,492 484,487
7,532 27,532 2017 483,256 483,251
6,905 27,148 1988 470,509 482,785
627 384 29 12,747 466
7,574 27,574 13,196 485,764 485,764
6,951 27,192 1989 472,898 485,185
7,575 27,575 30,635 485,764 485,764
6,946 27,189 2076 472,999 485,293
7,565 27,568 2017 485,277 485,261
6,938 27,183 1988 472,513 484,790
627 385 29 12,764 471
7,576 ND 51,259 485,763 ND
6,847 ND 47,632 470,417 ND
2 ND 435,427 923 ND
7,574 27,574 17,329 485,764 485,764
6,796 27,037 16,604 468,983 481,260
4 4 469,358 923 923
7,574 27,574 14,295 485,765 485,765
6,846 ND 2986 470,315 ND
ﬁltered for multiple hits.
Fig. 1. A. Venn diagram of uniquely mapping HM27 probes aligned using Blat, Novoalign, BWA and SHRiMP using default parameters. 219 probes were commonly identiﬁed as
uniquely aligning to the mm9 reference genome. Unique was deﬁned as 100% identity to the reference genome with only one alignment. B. Venn diagram of uniquely mapping
HM450 probes aligned using Blat, Novoalign, BWA and SHRiMP using default parameters. 1975 probes were commonly identiﬁed as uniquely aligning to the mm9 reference ge-
nome. C. Venn diagram of uniquely mapping HM27 probes aligned using three bisulﬁte short read aligners to the bisulﬁte converted mm9 reference genome. The aligners used
included Novoalign Bisulﬁte Mode (http://www.novocraft.com), Bsmap [11] and Bismark [12]. D. Venn diagram of uniquely mapping HM450 probes to the bisulﬁte converted
mm9 reference genome. E. The signal intensity distribution of all 485,577 probes found on the HM450 BeadArray. Mouse samples demonstrate low probe intensity distributions
indicative of a failed array. Tissue samples were taken from two C57BL/6 wild type mice (87 and 88) from bone marrow (BM), lymph nodes (lymph), heart, spleen and liver.
The sufﬁx numbers denote the replicates performed. 1.3HTT and 2.4HTT represent the two Hoxb8mouse cell lines. JWL is a human lymphoblastoid cell line that was used as a con-
trol. F. The signal intensity distribution of 13,715 uniquely aligning probes in bisulﬁte space. With the exception of 87_lymph which failed overall quality control, the intensity dis-
tribution of these probes is comparable to the human sample, JWL.
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quence alignments from the HM27 array to the mouse mm9 reference
genome increased to 333 using Brat and up to 3516 probes using
Novoalign in bisulﬁte mode (Table 1). In total, 123 probes uniquely
aligned to the bisulﬁte converted mouse reference genome using all
four aligners. However, 1185 probes were in consensus with 3 out of
4 bisulﬁte short read aligners used (Novoalign Bisulﬁte Mode, Bsmap
and Bismark (data not shown)). Given the variation of alignment out-
put from these aligners, it was difﬁcult to identify unique alignments.
Further, given the paucity of information on alignments made by Brat
and that Brat listed the least number of alignments, we believe Brat
may be overly conservative in calling unique alignments. We observed
this further by performing alignment to the probes found on the
HM450 BeadChip and subsequently conﬁrmed by assessing empirical
signal intensity from mouse samples analysed by this array (see
below).With all four aligners, 182 probes were identiﬁed to commonly
align while 13,533 probes were found using Novoalign, Bsmap and
Bismark (Supplementary Fig. 1A). We therefore used these three bisul-
ﬁte short read aligner for downstream analysis (Supplementary Table).
Using Novoalign Bisulﬁte Mode, Bsmap and Bismark we found
1308 and 13,715 probes to uniquely align to the mm9 reference
genome after bisulﬁte conversion (Figs. 1C and D) on the HM27 and
HM450 Inﬁnium BeadChips respectively (Supplementary Tables 5
and 6 respectively). We also performed the same in-silico alignment
of probes to the bisulﬁte converted hg19 reference human genome.
The majority of probes from both the HM27 and HM450 BeadChips
were found to align to the bisulﬁte-converted human genome se-
quence (Table 1). However, we observed notable differences between
the number of probes that mapped to the hg19 reference genome and
the number of unique alignments suggesting that a subset of probes
align to multiple locations across our human reference genome. As
we included the reference haplotype sequences within our reference
genome, the majority of these probes aligned to these sequences.
After removing haplotype sequences from our reference genome
we found that the number of mapped unique probes increased
(Table 1). These are presented in in Supplementary Tables 7 and 8.
2.4. Inﬁnium HM450 BeadChip DNA methylation analysis
To determine the extent of the utility of the probes we have iden-
tiﬁed in-silico for mouse DNA methylation analysis, we ﬁrst looked at
the distribution of probe signal intensity across the HM450 array after
analysis with a panel of genomic DNA derived from various mouseTable 2
Inﬁnium versus SEQUENOM DNA methylation summary.
Gene Inﬁnium
probe ID
Difference hg19
and mm9
SEQUENOM
CpG analysed
Inﬁnium HM27
1.3HTT 2.4HTT
HOXC12 cg19928450 2MM CpG 6 0.13 0.62
ZNF312 (FEZF2) cg19629292 PM CpG 6 0.06 0.73
DLX5 cg00096922 PM CpG 18 0.07 0.55
HOXA5 cg02248486 PM CpG 1 0.93 0.03
ARC cg24981018 2MM CpG 12 0.53 0.07
PAQR6 cg10046892 2MM CpG 3 0.25 0.73
HR cg12748258 2MM CpG 2.3.4.5 0.07 0.81
GDF10 cg07773116 2MM CpG 4 0.83 0.09
PRKCDBP cg18392783 7MM CpG 2.3.4 0.1 0.7
JARID2 cg01769037 1MM CpG 3 0.71 0.23
WIPI2 cg20592700 2MM CpG 32.33.34 0.02 0.02
KCNC3 cg06572160 2MM CpG 17 0.03 0.03
PEX5 cg15754084 2MM CpG 2 0.22 0.22
RAB20 cg20371891 3MM CpG 14.15 0.03 0.03
CREBL2 cg00261552 7MM CpG 12 0.04 0.04
GNA12 cg21685565 1MM CpG 22.23 0.02 0.02
PM = perfect match, 1MM = 1 mismatch, 2MM = 2 mismatches, 3MM = 3 mismatches,tissues and cell lines. We surmised that the intensity distribution of
Inﬁnium probes we predict to interrogate mouse genomic DNA sam-
ples would have a similar distribution to an analysis of a human geno-
mic DNA sample using the same probes. The intensity distribution of
all 485,577 probes on the HM450 BeadChip in all 11 mouse samples
tested was very low compared to that of a human sample used in
this study, JWL (Fig. 1E).
Taking only the 13,715 probes we have identiﬁed as uniquely
mapping to the bisulﬁte converted mm9 genome revealed an intensi-
ty distribution for 10/11 mouse samples similar to the human sample
JWL (Fig. 1F). One sample with a very low intensity distribution,
87_lymph, was indicative of a failed Inﬁnium analysis and this was
conﬁrmed with the on-board bisulﬁte conversion control probes on
the HM450 BeadChip (Supplementary Fig. 3).
The performance of these unique probes could also be assessed by
plotting the distribution of Beta scores called for all 485,577 probes.
This revealed a distinct distribution curve for all mouse samples
analysed when compared to the human sample, JWL (Supplementary
Fig. 1B). With the distribution peaking at a Beta score of 0.3 such a curve
in human sample analysis is indicative of a failed analysis. However,
plotting the beta distribution of the unique subset of 13,715 probes,
the distribution curves from the mouse samples were a similar shape
to the human sample analysed in the same experiment (Fig. 2A).
Unsupervised hierarchal clustering of samples using this subset of
probes suggests that distinct DNA methylation proﬁles can be mea-
sured using the HM450 array on mouse tissue samples (Fig. 2B). We
found a similar dendrogram structure taking gene expression data
from the Mouse Gene Atlas V3 (http://biogps.org, Table 4) of the
11,585 genes associated with this unique subset of Inﬁnium HM450
probes (Supplementary Fig. 1C).
To assess the reproducibility of the HM450 platform for analysing
mouse genomic DNA, we performed several replicate analyses. We
assessed array replication, bisulﬁte treatment replication, and biolog-
ical replication. High correlation was observed across all replicate
analyses performed. A Pearson's correlation coefﬁcient of 0.988 was
observed for array replication (Fig. 2C) where two HM450 BeadChips
were used to analyse the same mouse bone marrow sample
(88_BM_01). The same correlation was observed performing parallel
bisulﬁte conversions on genomic DNA derived from the same mouse
tissue sample (88_BM_01_1 and 88_BM_02 Fig. 2D). We assessed bi-
ological replication by comparing DNA methylation from bone mar-
row tissue of two mice and found a very high correlation coefﬁcient
of 0.989 (Supplementary Fig. 1D).Inﬁnium HM450 SEQUENOM
Difference 1.3HTT 2.4HTT Difference 1.3HTT 2.4HTT Difference
0.49 0.12 0.7 0.58 0.02 0.68 0.66
0.67 0.08 0.56 0.48 0.06 0.49 0.43
0.48 0.09 0.51 0.43 0 0.45 0.45
0.9 0.81 0.39 0.42 0.86 0.08 0.78
0.46 0.53 0.14 0.39 0.69 0.48 0.21
0.48 0.53 0.9 0.37 0.84 0.94 0.1
0.74 0.56 0.35 0.21 0.71 0.04 0.67
0.74 0.56 0.35 0.21 0.71 0.04 0.67
0.6 0.19 0.38 0.19 0.1 0.27 0.17
0.48 0.09 0.16 0.07 0.08 0.06 0.02
0 0.25 0.2 0.05 0.03 0.05 0.02
0 0.05 0.1 0.05 0 0.01 0.01
0 0.82 0.78 0.05 0.08 0.01 0.07
0 0.18 0.17 0.02 0.01 0.04 0.03
0 0.07 0.07 0 0.03 0.06 0.03
0 0.01 0.02 0 0.09 0.07 0.02
7MM = 7 mismatches.
Table 3
SEQUENOM primers used in this study.
Inﬁnium ID Chr Start Symbol Forward primer Reverse primer
cg02248486 chr6 52,154,271 HOXA5 aggaagagagGTAAATTTTGTTTGATGATTTTTAGAG cagtaatacgactcactatagggagaaggctTAATTTTACCATAATAAACTATAACCTCAA
cg07773116 chr14 34,737,279 GDF10 aggaagagagTGTAGGGGGATAGGGATTTTTAGTA cagtaatacgactcactatagggagaaggctCAAAAAATCTACCACCAAATACCAC
cg12748258 chr14 70,954,710 HR aggaagagagTATAGTTTTGGTTTAGAAGTTGGTG cagtaatacgactcactatagggagaaggctTTAAAATCAACTCATAAACTCCCCC
cg19629292 chr14 13,178,127 ZNF312 aggaagagagGGGAATTGGGTATTGAAAGAGTAAA cagtaatacgactcactatagggagaaggctATCATTCCACTTCAAATAACTTCATA
cg19928450 chr15 102,767,199 HOXC12 aggaagagagTTTTTATTTAGGATTGGGGAAGG cagtaatacgactcactatagggagaaggctCACAAACCCAAAATTCAAAAAATTA
cg00096922 chr6 6,832,079 DLX5 aggaagagagTTGGTTTATGGAGGGAAAGATGTAT cagtaatacgactcactatagggagaaggctCCATTATCTACCAAAAAACTCTAACC
cg10046892 chr3 88,167,813 PAQR6 aggaagagagGTAGGGTTTGGAGAGTTTTGTTGTA cagtaatacgactcactatagggagaaggctCCAACTTAAACCCCTAACCTAATCT
cg01769037 chr13 44,827,083 JARID2 aggaagagagTTGATTGTAAAAGGGGATAATTGTT cagtaatacgactcactatagggagaaggctACAAATCAAATACTAAAAACCTTCAC
cg24981018 chr15 74,502,498 ARC aggaagagagTGGTAGTAGGGTTTTGGATTTTTTA cagtaatacgactcactatagggagaaggctCCAAACCCAATATAATCCTACAAATTA
cg20371891 chr8 11,478,337 RAB20 aggaagagagGTAAGGTAAGTGGGAATAGAGGTGT cagtaatacgactcactatagggagaaggctTCTCAAACCAAAACCACTAAAATTC
cg06572160 chr7 51,846,699 KCNC3 aggaagagagGTATTTTGTTAGGGATTAGATTGGT cagtaatacgactcactatagggagaaggctTAAATCATCCAACAACAAACCTCC
cg15754084 chr6 124,364,404 PEX5 aggaagagagAGGGGTTAGGTTTTAGTTTTTTTTG cagtaatacgactcactatagggagaaggctAAAACACAACCTCCTCTTAAACTCC
cg20592700 chr5 143,105,745 WIPI2 aggaagagagTTTTGGAGTATAAATAAGAGTGGGGA cagtaatacgactcactatagggagaaggctCTCAACCTAACCAACCCTAATCTCT
cg21685565 chr5 141,305,942 GNA12 aggaagagagTTTTTGAGAGTGGTTTAGTTTGTATTTT cagtaatacgactcactatagggagaaggctACAAATCCACCTTCCTCAAACAAAT
cg00261552 chr6 134,780,245 CREBL2 aggaagagagGAGGGGGTTAATTAGTTTGTAGAGT cagtaatacgactcactatagggagaaggctTCAAAACTTACCTTACTATCATCCA
cg18392783 chr7 112,630,274 PRKCDBP aggaagagagGAGAGGGATGTTTGAGGTTATTGAT cagtaatacgactcactatagggagaaggctCCTTACTAAAAAAATTAACCACCAT
Table 4
Publically available mouse expression datasets used in our study.
GEO identiﬁer Tissue type Sample ID
GSM258627 Bone marrow 4MJW06120841
GSM258628 Bone marrow 4MJW06120842
GSM258669 Heart 4MJW061208131
GSM258670 Heart 4MJW061208132
GSM258691 Lymph nodes 4MJW06120839
GSM258692 Lymph nodes 4MJW06120840
GSM258767 Spleen 4MJW061208161
GSM258768 Spleen 4MJW061208162
42 N.C. Wong et al. / Genomics 102 (2013) 38–462.5. Annotation and conservation between mm9 and hg19
Before embarking on this study we originally surmised that highly
conserved genomic regions exist and the HM450 BeadChip is agnostic
to which organism the genomic DNA analysed originated from. Our
in-silico analysis identiﬁed 13,715 probes that uniquely mapped to
the mm9 reference genome. The proportion of valid Inﬁnium Type I
and Inﬁnium Type II probes for mouse interrogation is comparable to
the proportion found on the entire HM450 BeadChip (31% and 69% re-
spectively (Fig. 2F i)). The total proportion of Type I and Type II probes
on the HM450 BeadChip is 28% and 82% respectively. To determine the
extent of sequence conservation, the co-ordinates of the uniquely
mappedprobeswere used to create an annotation table to themm9 ref-
erence genome using the annotatePeaks.pl tool from Homer (http://
biowhat.ucsd.edu/homer/ngs/index.html) [13], a ChIP-Seq peakﬁnding
and annotation tool.We compared the gene assigned to the probe using
mm9 annotations with the gene assigned to the probe annotated to
the hg19 reference genome. By comparing the gene symbol annotation
and the RefSeq ID annotations, if a match is found between the mouse
and human annotations of these probes, we would accept that the se-
quence is conserved between these two species. Of the 13,715 probes
annotated, 75% (10,331 probes) were conserved between mouse and
human representing 4542 conserved genes (Supplementary Table 11)
the HM450 BeadChip can interrogate on mouse samples.
2.6. Using the HM450 BeadChip to investigate mouse biology
Of the 13,715 probes we have taken tomeasure DNAmethylation in
mouse samples, we calculated the standard deviation of Beta scores forFig. 2. A. The Beta score distribution of 13,715 uniquely mapping probes in bisulﬁte space o
mouse samples analysed, was comparable to the human sample, JWL. B. Dendrogram depic
this study. The tree layout is comparable to a tree derived from the publicly available Mou
results from array replication (same sample, two distinct arrays). D. Scatter plot depicting hi
iable DNA methylation probes in mouse samples. F. i. Distribution of Inﬁnium Type I and In
parable to the distribution of all probes on the HM450 BeadChip. F. ii. The proportion of hieach probe across the 11 samples we have analysed using the HM450
BeadChip. Setting a variation cut-off of 0.2 or greater standard devia-
tions, 237 probes demonstrated high variation of Beta score across the
samples we analysed (Fig. 2E). We performed DAVID [14] and GOrilla
[15] ontology analysis on the genes associatedwith these probes. Ontol-
ogy analysis revealed strong enrichment in developmental processes
and cell signalling (Supplementary Table 9) indicative of tissue speciﬁc
DNA methylation changes in the mouse tissue samples analysed.
We also investigated the extent of DNA methylation changes in an
inducible Hoxb8 mouse cell line model of acute myeloid leukaemia.
This model cell line contains an inducible Hoxb8 expression system
under the control of tamoxifen.
Continuous expression of Hoxb8 is absolutely required to maintain
the leukemic phenotype of this cell line and we can investigate
changes in DNA methylation as a result of Hoxb8 expression [16].
We measured DNA methylation before (1.4HTT) and after Hoxb8
(2.4HTT) induction to identify changes in DNA methylation as a conse-
quence of Hoxb8 expression using the HM450 BeadChip. We identiﬁed
738 probes having greater than 0.2 standard deviations of variation be-
fore and after Hoxb8 induction. These probes were associated with 568
genes and after DAVID ontology analysis, found to be enriched with
developmental, differentiation and homeobox processes known to be
affected by the induction of Hoxb8 [16] (Supplementary Table 10).2.7. SEQUENOM EpiTYPER validation of HM450 mouse DNA
methylation calls
We selected 16 Inﬁnium probes demonstrating a range of Beta
score differences before and after Hoxb8 induction in the model
mouse cell line for SEQUENOM EpiTYPER replication. The probes
selected for validation had Beta score differences as high as 0.58
and contained up to 7 mismatches to the reference bisulﬁte mouse
genome (Table 2). An overall correlation between SEQUENOM and
HM450 methylation measurements of 0.48 was observed (Supple-
mentary Fig. 2A). We observed good correlation in DNA methylation
between SEQUENOM and HM450 selected with a large or no
beta difference (Supplementary Fig. 2A). Poor correlation between
SEQUENOM and HM450 was observed for HoxA5 and GDF10 which
all demonstrated intermediate beta differences by HM450 BeadChip
analysis (Supplementary Fig. 2B). From our results, it would seemf mm9 found on the HM450 BeadArray. The shape of the distribution curve from all the
ting the level of similarity in DNA methylation proﬁles across the samples analysed in
se Gene Atlas dataset (http://biogps.org). C. Scatter plot depicting highly reproducible
ghly reproducible results from bisulﬁte conversion replication. E. Heatmap of most var-
ﬁnium Type II probes that could be used to interrogate mouse genomic DNA was com-
ghly conserved probes was also identiﬁed.
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mismatches are tolerable (Table 2).3. Discussion
With the increasing popularity of genome-wide DNA methylation
BeadChips in human studies, interest in an equivalent mouse platform
has been mounting. In its absence, we investigated the utility of
Illumina Inﬁnium Human Methylation BeadChips for the analysis of
DNAmethylation inmouse samples. Recent xeno-array studies have in-
vestigated genomewide gene expression and found that it was possible
to estimatewithin-species differences using amicroarray from a closely
related species [4,17]. It has also been demonstrated that sequences
with greater than 75% similarity to a 50-mer target probe are able to
cross hybridize giving rise to unreliable intensity measurements [18].
Unlike gene expression microarrays that solely rely on hybridization,
the chemistry used by this Inﬁnium BeadChip requires both probe
hybridization and base extension to ﬂuorescently label the probe for a
positive read out [6]. Nevertheless, to minimize the possibility of cross
hybridization, we decided to investigate Inﬁnium probes that mapped
uniquely to the mouse reference genome using a panel of short read
aligners.
Both the reference genome sequence (base space) and bisulﬁte
converted reference genome sequence (bisulﬁte space) were used
as reference genomes from hg19 and mm9 for in-silico alignment.
We found that Blat, Novoalign, BWA and SHRiMP identiﬁed similar
uniquely mapping probes to the mouse genome even though their
underlying alignment algorithms are different (Figs. 1A and B).
The Illumina Inﬁnium Human Methylation Bead Chip interrogates
genomic DNA in bisulﬁte genome space. Therefore it is more appropri-
ate to perform alignment analysis taking into account bisulﬁte conver-
sion of genomic DNA. Unlike the genome space short read aligners
above, bisulﬁte short read aligners have been developed more recently.
It is unclear which bisulﬁte aligner performs the best. Here we tested
four aligners that account for bisulﬁte conversion, Bsmap [11], Bismark
[12], Brat [10] and Novoalign in bisulﬁte mode (http://www.novocraft.
com). These aligners take into account nucleotide degeneracy afforded
by bisulﬁte treatment, unmethylated cytosine converts to thymine
after bisulﬁte conversion and PCR ampliﬁcation while methylated
cytosines remain as cytosine. Furthermore, the Watson and Crick
strands of genomic DNA become non-complimentary after bisulﬁte
conversion effectively doubling the size of the genome and increasing
the chances of alignment of a 50-mer probe. Bsmap, Bismark, Brat and
Novoalign in bisulﬁte mode handle this in their own way so we set
out to identify probes that mapped and were in common with the
aligners used. We found early in our analysis that Brat seemed over-
conservative and it was unclear howmapping was scored by this align-
er. We therefore used Bsmap, Bismark and Novoalign in bisulﬁte mode
for analysis.
After mapping to the bisulﬁte converted reference genome, we
found 1308 and 13,715 probes uniquely mapped to bisulﬁte space
from the HM27 and HM450 BeadChips respectively. The performance
of these probes was assessed and we found Beta score measurements
from them to be reproducible with good correlation between techni-
cal and biological replicates and, reliable with good correlation of
DNA methylation measured using an independent assay, SEQUENOM
EpiTYPER.
These probes could be used to identify tissue speciﬁc DNA methyla-
tion changes in mouse tissues and offer a potentially robust and viable
option of array-based DNA methylation screening in the absence of a
purpose built microarray for measuring DNA methylation in mouse
samples. Using a model mouse cell line of acute myeloid leukaemia
[16] we have been able to detect large changes of DNA methylation as
a result of Hoxb8 activation. The DNA methylation differences of these
probes are associated with genes important in cell differentiation andhomeobox processes conﬁrming that the HM450 platform canmeasure
biologically relevant changes in mouse samples.
Finally, in-silico alignment and annotation of the Inﬁnium HM27
and HM450 probes to the reference mouse genome (mm9) revealed
a signiﬁcant proportion of usable probes that are highly conserved be-
tween human and mouse. Of note, performing in-silico alignment
using Blat to hg19 we found 627 HM27 probes and 12,764 HM450
probes that appeared to map to multiple locations within our refer-
ence genome (Table 1). Our reference hg19 genome included haplo-
type reference sequences and the majority of these probes mapped
to the haplotype reference sequences. Nevertheless these probes
should be noted in future epigenome-wide association studies
(EWAS) where the genetic effect of haplotype could confound epige-
netic effects.
When using short read aligners that take into account bisulﬁte con-
version of the genome, we found that up to 3% of probes on both the
HM27 (729 and 778 probes fromNovoalign BisulﬁteMode and Bismark
respectively) and HM450 (15,346 and 16,781 probes from Novoalign
Bisulﬁte Model and Bismark respectively) BeadChips mapped to haplo-
type sequences (derived from Table 1). This can been seen from
Bismark alignments where we found 468,983 uniquely aligning probes
to the hg19 reference genome with the haplotype sequences that in-
creased to 481,260 unique probes with the haplotype sequences re-
moved from our reference sequence (Table 1). It has been highlighted
previously that sex-speciﬁc methylation differences observed on the
Inﬁnium HM27 array arose from probe sequence cross-reactivity [19].
We speculate that haplotype in a population-based study of DNA
methylation by EWAS could confound methylation observations from
probes that map to the reference haplotype sequences. We have identi-
ﬁed probes that map to the haplotype reference sequences from the
current InﬁniumHM27 and HM450 BeadChips and list them in Supple-
mentary Tables 7 and 8.
In the absence of an Inﬁnium Methylation Mouse BeadChip, we
present the utility of the Illumina Inﬁnium HM27 and HM450
BeadChip for analysingmouse samples for DNAmethylation.We dem-
onstrate that a subset of probes found on this array is able to interro-
gate the mouse genome for DNA methylation. Through our analysis,
we have also identiﬁed potentially unreliable probes on both 27k
and 450k platforms that map to multiple locations across the refer-
ence human genome (hg19) that should also be taken into account
along with sex-speciﬁc probes [19] and single nucleotide polymor-
phisms [20]. From our study, we suggest that the currently available
HM450 BeadChip could be a viable and affordable option to gain bio-
logical insight into the role of DNA methylation in model mouse sys-
tems .
4. Methods
4.1. In-silico analysis
Probe target sequences interrogated by the HM27 and HM450
array were extracted from the annotation library IlluminaHuman-
Methylation27k.db and IlluminaHumanMethylation450k.db respec-
tively in Bioconductor (http://www.bioconductor.org). Probe target
sequences were aligned using a range of short read aligners against
the mouse (mm9) or human (hg19) reference genomes. For the
human reference genome we constructed two reference genomes,
one that contained all known reference haplotype sequences and an-
other without these reference haplotype sequences (nohap). Genome
indices required for each aligner were constructed as outlined in the
respective user manuals. Aligners included, BWA 0.5.9 [21], SHRiMP
2.1.1 [22], Novoalign 2.05.32 (http://www.novocraft.com) and Blat
v34 [23]. Default parameters were used for all aligners.
Using Samtools, probes were ﬁltered for alignment, no mismatches
(using SAM tags including H0:i:1 (number of perfect hits), NM:i:0
(edit distance from reference) and NH:i:1 (number of reported
45N.C. Wong et al. / Genomics 102 (2013) 38–46alignments) depending on the output of the aligner used) and in Ge-
nome Space, 50 base alignments. Non-unique alignments were ﬁltered
using the uniq command. Speciﬁc tags generated by BWA after align-
ment including X0:i:1 (number of best hits) and XT:A:U (unique align-
ment) were used to extract unique alignments. To obtain perfect
alignments from Blat, a minimum identity of 100% was set. The script
ﬁles and resultant alignment ﬁles can be found in Supplementary data.
Novoalign had the added feature of alignment in bisulﬁte se-
quence space that aligns bisulﬁte converted short reads to both the
Watson and Crick strands after bisulﬁte conversion. Inﬁnium probe
sequences were mock-converted using the ﬁnd and replace function
of the Unix command sed. Additional aligners that take into account
bisulﬁte conversion of the genome were also used. These were
Bsmap [11], Bismark [12], and Brat [10] with default parameters.
All alignments were performed at the Peak Computing Facility,
Victorian Life Sciences Computation Initiative (http://www.vlsci.org.au).
Scripts and result ﬁles are supplied as Supplementary information.
4.2. Mouse cell lines, tissues and growth conditions
Cell lines were generated as previously described [24]. Brieﬂy,
haematopoietic progenitor cells were harvested from E14.5 C57BL/6
embryos and infected with lentivirus encoding murine Hoxb8 under
the control of a 4-hydroxy tamoxifen (4-OHT) inducible promoter.
Cells were cultured in 0.25 ng/ml interleukin-3 (IL-3) and 0.1 μM
4-OHT. Clones were then selected after replating in semi-solid culture
media (0.3% soft agar, 20% fetal calf serum (FCS), 0.3 ng/ml IL-3,
0.1 μM 4-OHT in DMEM). All clones were tested to ensure that viability
and proliferation remained strictly dependent on IL-3 and Hoxb8. Cells
are maintained in DMEMwith 10% FCS, IL-3 and 4-OHT. Cells no longer
expressing Hoxb8were prepared by removing 4-OHT from culture for a
period of four days. Mouse tissue were harvested from two C57BL/6
mice and stored in DirectPCR (Tail) lysis reagent (Viagen) at 4 °C. Tissue
wasmacerated prior to lysis, proteinase K digestion and phenol chloro-
form extraction of genomic DNA. After spectrophometry, genomic DNA
was quantiﬁed then processed as outlined below.
4.3. Inﬁnium HM27 and HM450 BeadChip analysis
Genomic DNA extracted from a model Hoxb8 transformed mye-
loid cells and from various tissues from C57BL/6 mice. Hoxb8 is
under the control of a 4-hydroxy-tamoxifen inducible promoter
[16]. We compared the DNA methylation proﬁle from cells before
(−HOXB8) and after (+HOXB8) Hoxb8 induction using the Illumina
HumanMethylation27 and HumanMethylation450 BeadChips [6].
DNA was bisulﬁte converted with MethylEasy Xceed Kit (Genetic Sig-
natures, Sydney, Australia) according to manufacturer's instructions.
Samples were then processed and analysed by the Australian Geno-
mics Research Facility (AGRF, Melbourne, Australia) according to
manufacturer's instructions (Illumina, San Diego). Raw data after
scanning and hybridization was processed using lumi, a Bioconductor
library within the R environment [25]. Raw data was initially used to
determine intensity distributions. Inﬁnium methylation probes were
ranked by beta value difference and selected for SEQUENOM veriﬁca-
tion. Raw data has been submitted to GEO (GSE43226).
4.4. SEQUENOM EpiTYPER DNA methylation analysis
Bisulﬁte primers were designed to amplify the region of the mm9
genome that ﬂanked the Inﬁnium probe sequences of interest.
The mm9 genomic location of the Inﬁnium probes of interest were
searched using Blat [23]. 500 bp ﬂanking the probe sequence was
extracted for SEQUENOM EpiTYPER primer design using EpiDesigner
(http://www.epidesigner.com). The primer sequences used are listed
in Table 3. SEQUENOM EpiTYPER chemistry was performed as
outlined in [26].Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.ygeno.2013.04.014.Acknowledgments
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